Humacyte, Inc. Warrant (expiring August 27, 2026) (HUMAW)
Market Closed
11 Aug, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 01
0
0%
$
9.63M Market Cap
- P/E Ratio
- Div Yield
800 Volume
-0.9 Eps
$ 0.01
Previous Close Want to track HUMAW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
HUMAW Earnings Reports FAQ
What is the earnings per share (EPS) for HUMAW?
The current EPS is -0.9.
What is the company's earnings growth rate?
Humacyte, Inc. Warrant (expiring August 27, 2026) has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Humacyte, Inc. Warrant (expiring August 27, 2026) has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Humacyte, Inc. Warrant (expiring August 27, 2026) are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for HUMAW at this time, as Humacyte, Inc. Warrant (expiring August 27, 2026) has no recent EPS data to calculate it.
